26:01

Aspectos destacados del cáncer de pulmón en ASCO 2025: CheckMate 816, ToD, NeoADAURA, IMforte, De...

5:50

IMforte Study Results from ASCO 2025 & WCLC 2025 by Dr. Stephen Liu

4:48

ASCO 2025: Dr. Liu Discusses the Most Anticipated Thoracic Oncology Data To Be Presented

30:53

Immunotherapy Side Effects: What Patients Need to Know with Dr. Jeffery Weber

5:22

ALK Positive at ASCO 2025: Ken Culver, MD, Reflects on Experiences, Importance of Patient Advocacy